Medications for AML include chemotherapy and newer targeted therapies. With several options available, the right medication for you will depend on the specific characteristics of your cancer. Acute ...
Kyowa Kirin’s big bet on Kura Oncology has paid off in short order, delivering an FDA approval for a medicine to treat a ...
Less than a month after signing a one-day contract with the Minnesota Wild through the Make-A-Wish Foundation, 10-year-old ...
Two phase 3 trials will study Kura Oncology’s ziftomenib for frontline acute myeloid leukemia, one with venetoclax and the ...
Diets that contain high levels of the nutrient selenium may help stave off myeloid leukemia, suggests new research published in Cell Reports. Selenium is a trace mineral that can be found in many ...
PRIMETIMER on MSN
MN Wild young fan GoFundMe donations surge as team pays tribute to 10-year-old who died from leukemia
Weston Paszkiewicz, a 10-year-old suffering from Leukemia, spent two memorable games with his favorite team, MN Wild ...
NPM1 mutations, one of the most common genetic drivers of AML, are now actionable for patients –– Acute unmet need in R/R ...
Medpage Today on MSN
Two Drugs Approved for NPM1-Mutated Leukemia
Ziftomenib (Komzifti) was approved on Thursday for adults with relapsed/refractory NPM1 -mutated AML who have no satisfactory ...
Targeting a specialized group of histones is safe and opens new therapeutic opportunities for treating blood cancers, a new study reveals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback